-
Announced18/12/2023
-
Today15/08/2026
Utilities
- indicates text translated automatically in your browsing language
Italy-Teramo: Vaccines
The purpose of the exploratory public notice is to identify a pharmaceutical company to which, following a public tendering procedure, the exclusive right to use Master Seed Virus for the production and marketing, in Italy and abroad, of the inactivated vaccine against EHDV-8, in order to combat the spread of the virus and protect animals from infection, allowing animals to be moved safely from restricted areas.
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.